open access

Vol 15, No 4 (2008)
Original articles
Published online: 2008-05-21
Get Citation

Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol

Jadwiga Nessler, Bohdan Nessler, Mariusz Kitliński, Marek Stępniewski, Wiesława Piwowarska
Cardiol J 2008;15(4):329-337.

open access

Vol 15, No 4 (2008)
Original articles
Published online: 2008-05-21

Abstract

Background: To analyze differences in brain natriuretic peptide (BNP) levels depending on mitral flow pattern (MFP) and to assess the effects of carvedilol on changes in MFP, left ventricular function and exercise capacity.
Methods and results: The study population consisted of 73 patients with symptomatic heart failure in NYHA classes II and III and LVEF < 40% without prior beta-blockade. In all patients at baseline, before carvedilol, and then at 3 and 12 months after initiation of treatment, the following parameters were assessed: HRs, serum BNP, echocardiographic parameters, and exercise capacity with gas monitoring during cardiopulmonary stress test. Before carvedilol there was a positive correlation between BNP and E/A (r = 0.17; p = 0.05). BNP was significantly higher in patients with restrictive MFP (rMFP) as compared with nonrestrictive MFP (nrMFP) (541.5 ± 206.7 vs. 412.6 ± 207.2; p = 0.009), and lower VO2peak in rMFP as compared with nrMFP (12.5 ± 3.7 vs. 16.5 ± 4.7; p = 0.001). After initiation of carvedilol, the patients with rMFP had reduced E/A (2.9 vs. 1.4; p = 0.003), and rMFP was changed to nrMFP in 60.8% of patients. Respective BNP concentrations were 342.16 ± 284.31 vs. 326.40 ± 264.6; NS. In patients with rMFP VO2peak , %N increased significantly from 42.4 ± 10.2 to 52.4 ± 14.4; p = 0.012.
Conclusions: In patients with systolic congestive heart failure, the presence of rMFP is related to higher BNP levels and reduced VO2peak. Chronic treatment with carvedilol replaces rMFP with nrMFP and improves exercise capacity in some patients.

Abstract

Background: To analyze differences in brain natriuretic peptide (BNP) levels depending on mitral flow pattern (MFP) and to assess the effects of carvedilol on changes in MFP, left ventricular function and exercise capacity.
Methods and results: The study population consisted of 73 patients with symptomatic heart failure in NYHA classes II and III and LVEF < 40% without prior beta-blockade. In all patients at baseline, before carvedilol, and then at 3 and 12 months after initiation of treatment, the following parameters were assessed: HRs, serum BNP, echocardiographic parameters, and exercise capacity with gas monitoring during cardiopulmonary stress test. Before carvedilol there was a positive correlation between BNP and E/A (r = 0.17; p = 0.05). BNP was significantly higher in patients with restrictive MFP (rMFP) as compared with nonrestrictive MFP (nrMFP) (541.5 ± 206.7 vs. 412.6 ± 207.2; p = 0.009), and lower VO2peak in rMFP as compared with nrMFP (12.5 ± 3.7 vs. 16.5 ± 4.7; p = 0.001). After initiation of carvedilol, the patients with rMFP had reduced E/A (2.9 vs. 1.4; p = 0.003), and rMFP was changed to nrMFP in 60.8% of patients. Respective BNP concentrations were 342.16 ± 284.31 vs. 326.40 ± 264.6; NS. In patients with rMFP VO2peak , %N increased significantly from 42.4 ± 10.2 to 52.4 ± 14.4; p = 0.012.
Conclusions: In patients with systolic congestive heart failure, the presence of rMFP is related to higher BNP levels and reduced VO2peak. Chronic treatment with carvedilol replaces rMFP with nrMFP and improves exercise capacity in some patients.
Get Citation

Keywords

restrictive filling pattern; heart failure; carvedilol

About this article
Title

Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol

Journal

Cardiology Journal

Issue

Vol 15, No 4 (2008)

Pages

329-337

Published online

2008-05-21

Bibliographic record

Cardiol J 2008;15(4):329-337.

Keywords

restrictive filling pattern
heart failure
carvedilol

Authors

Jadwiga Nessler
Bohdan Nessler
Mariusz Kitliński
Marek Stępniewski
Wiesława Piwowarska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl